Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED)
PHASE2
This is a Multi-center, Double-blind, Randomized, Placebo-controlled, Paral...
Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients
PHASE2
This will be a double-blind, randomised, placebo-controlled parallel-arm ph...
Status
Completed
Location
Universitätsklinik für Innere Medizin VI Innsbruck, Neurologisches Studienzentrum